Understanding AndroGel Lawsuits: What You Need to Know
AndroGel, a popular testosterone replacement therapy (TRT) gel, has been the subject of numerous lawsuits over the years. These legal actions have raised significant concerns about the safety and marketing practices associated with the product. In this blog, we'll dive into the background of AndroGel, the nature of the lawsuits, key legal outcomes, and what it all means for patients considering or currently using testosterone replacement therapy. What is AndroGel? AndroGel is a topical testosterone gel used to treat men with low testosterone levels, also known as hypogonadism. It is applied to the skin, allowing testosterone to be absorbed into the bloodstream. The gel is designed to help restore normal testosterone levels, which can improve symptoms such as low libido, fatigue, and muscle weakness. The Rise of Lawsuits The wave of lawsuits against AndroGel's manufacturer, AbbVie Inc. (a subsidiary of Abbott Laboratories), primarily began in the early 2010s. The key